OGN's logo.
Ticker Symbol: OGN

Organon & Co.

$33.54 - 20-12-2024 4 p.m. ET

Exchange: NEW YORK STOCK EXCHANGE INC. Country: United States Currency: USD Asset Type: Common Stock CIK:0001821825

Company Profile

Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Here for her health, the company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets. Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,000 employees with headquarters located in Jersey City, New Jersey.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 2000 Galloping Hill Road
CEO: Kevin Ali
Tags: N/A

Pricing

Last Updated: October 3, 2023 03:02 PM EST
Previous Close: $16.29
Change: -$0.40 ( -2.40%)
Days Range: $16.13 - $16.67
Beta: 0.91
52wk. High: $31.28
52wk. Low: $15.96
Ytd. Change -40.44%
50 Day Moving Average: $18.03
200 Day Moving Average: $20.57
Shares Outstanding: 255568321

Valuation

Market Cap: 416.3B
PE Ratio: 5.52
EPS (TTM): 2.95

Dividends

Dividend Per Share (TTM): $1.09
Dividend Yield (TTM): 6.79%
Ex-Dividend Date: August 17, 2023